The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials고강도 항응고제 투여가 COVID-19 입원 환자의 임상 결과에 미치는 영향: 무작위 대조 시험의 메타 분석Meta-Analysis Published on 2022-02-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI 95% confidence interval Analysis Anticoagulant anticoagulation bleeding clinical benefit Clinical outcome clinical outcomes controlled trials Course COVID-19 database enoxaparin Evidence heparin hospitalized patient hospitalized patients identify major bleeding major bleeding event major bleeding events meta-analyses Meta-analysis Mortality no significant difference no statistically significant difference Odds ratio outcome Patient Prophylactic prophylactic anticoagulation random-effects model Random-effects models Randomized controlled trial Randomized controlled trials severe COVID-19 significantly increased statistically significant difference statistically significant reduction subgroup analysis systematic literature search therapeutic anticoagulation Thromboembolism thrombotic thrombotic event Thrombotic events was performed were used with COVID-19 [DOI] 10.1016/j.jiac.2021.11.008 PMC 바로가기 [Article Type] Meta-Analysis
Coronary Stent Thrombosis in COVID-19 Patients: A Systematic Review of Cases Reported WorldwideReview Published on 2022-01-272022-10-28 Journal: Viruses [Category] COVID-19, [키워드] activate Analysis available data catastrophic caused Complication Coronary Coronary artery COVID-19 COVID-19 pandemic death Frequency increase Inflammatory lack Local mechanism Myocardial infarction Occurrence outcome Patient Percutaneous coronary intervention performed predictor prothrombotic environment public health Research review risk SARS-CoV-2 Stent stent thrombosis subgroups Thromboembolism thrombosis [DOI] 10.3390/v14020260 PMC 바로가기 [Article Type] Review
Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectivesReview Published on 2022-01-252022-10-31 Journal: Cellular and Molecular Life Sciences [Category] COVID-19, [키워드] affecting Anti-citrullinated proteins antibodies (ACPAs) arginine Autoimmune biochemical Cancer Cell cellular metabolism chromatin Citrullination citrulline clinical trial consequence conserved COVID-19 enzyme Evidence expressed function Gene Expression glycosylation human tissues immune disorders Inflammatory inflammatory disease information inhibitor less metabolism Methylation modulating multiple sclerosis neutrophil extracellular traps (NETs) Numerous pathology pathway peptidylarginine deiminases (PADs) Periodontitis Perspective Phosphorylation post-translational modification prevalent Protein Proteins rheumatoid arthritis subject systemic lupus erythematosus Therapeutic approach Thromboembolism variety [DOI] 10.1007/s00018-022-04126-3 PMC 바로가기 [Article Type] Review
Anti-phospholipid antibodies in the setting of thromboembolic events associated with severe COVID-19 pneumoniaResearch Published on 2022-01-182022-10-31 Journal: Egyptian Rheumatology and Rehabilitation [Category] COVID-19, [키워드] analyzed anti-cardiolipin antibody Anti-phospholipid antibodies antibodies antibody arterial thromboembolism bowel cohort study Confirmed COVID-19 infection consecutive patient consequence COVID pneumonia COVID-19 COVID-19 infection COVID-19 patients Critically ill demonstrated Frequency highest Hospital admission IgM immunoassays incidence include increased risk individual Ischemia limb Most patient Multiple Myocardial infarction outcome Patient patients positive Prevalence Pulmonary embolism renal reported Result risk Severe COVID-19 pneumonia severe pneumonia significant changes in stroke supported survived tested Testing Thromboembolic event Thromboembolism thrombosis thrombotic Thrombotic events Venous Thromboembolism [DOI] 10.1186/s43166-021-00105-x PMC 바로가기 [Article Type] Research
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism RegistryArticle Published on 2022-01-182022-10-28 Journal: Viruses [Category] COVID-19, [키워드] 95% confidence interval accompanied acute respiratory syndrome adenovirus-based Clinical characteristics clinical outcomes controls coronavirus COVID-19 Day major bleeding Moderna Mortality mortality rate mRNA-based not significantly different occur Odds ratio outcome Patient platform Prospective Study recruited registry SARS-CoV-2 selected study outcomes Thromboembolism thrombosis vaccination venous Venous Thromboembolism VTE [DOI] 10.3390/v14020178 PMC 바로가기 [Article Type] Article
Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patientsResearch Article Published on 2022-01-122022-10-28 Journal: PLoS ONE [Category] COVID-19, [키워드] 95% CI adjusted affected age All the patient ARDS association Cohort complication of COVID-19 condition correlated COVID-19 infection COVID-19 patient CPAP cut off value D-dimer value Deep venous thrombosis Diagnosis DVT evaluate Evidence identify incidence Increased Infection International Local moderate-severe Mortality Multivariate analysis non-ICU patient occur Occurrence paO2/fiO2 Patient patients performed pharmacological Pneumonia positive airway pressure Prevent Prophylaxis protocol provoking receiving recommendations Result Retrospective analysis risk factor significantly Thromboembolism Thromboprophylaxis thrombosis Univariate analysis Upper extremity upper limb venous Ventilation were used [DOI] 10.1371/journal.pone.0262522 PMC 바로가기 [Article Type] Research Article
A Case of Intracardiac Thrombus in a Recovery Coronavirus Disease 2019 (COVID-19) PatientCardiology Published on 2022-01-052022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Affect chronic obstructive Coronavirus disease 2019 COVID-19 covid-related hypercoagulability described Diabetes Mellitus End-stage renal disease heart failure hypercoagulability hypertension intracardiac Intracardiac thrombus male past medical history pulmonary disease Respiratory system sar-cov 2 infection Shortness of breath shown thought thrombo embolic disease Thromboembolism thrombosis Thrombus Venous Thromboembolism with COVID-19 [DOI] 10.7759/cureus.20972 PMC 바로가기 [Article Type] Cardiology
Cavitary lung lesions in a neonate: Potential manifestation of COVID-19 related multisystem inflammatory syndrome신생아의 공동 폐 병변: COVID-19 관련 다기관 염증 증후군의 잠재적 징후Case Reports Published on 2022-01-012022-09-12 Journal: Pediatric pulmonology [Category] MERS, SARS, 진단, [키워드] antibody C-reactive protein cavitary Chest children COVID-19 COVID-19 infection CRP Culture Diagnosis elevated evaluated Evidence fast breathing ferritin Fever hyperinflammatory state Infant Inflammatory Intravenous immunoglobulin lactate dehydrogenase lesion leucocyte lung lung lesion MIS MIS-C Multisystem inflammatory syndrome Neonate nodule polymerase chain positive Potential Pregnancy procalcitonin pulmonary cavities resolution of symptoms syndrome thromboembolic complication thromboembolic complications Thromboembolism tomography treated Treatment [DOI] 10.1002/ppul.25732 PMC 바로가기 [Article Type] Case Reports
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trialRandomized Controlled Trial Published on 2022-01-012022-10-05 Journal: Lancet (London, England) [Category] 임상, [키워드] 1:1 95% CI allergic reaction Analysis anticoagulation assigned Asymptomatic Bayer blinded Brazil carried Clinical outcome conducted Controlled trial COVID-19 D-dimer D-dimer level death discharged Efficacy elevated eligibility enrolled FIVE Follow-up high risk hospital discharge hospitalisation hospitalised increased risk intensive care intention-to-treat intention-to-treat analysis intention-to-treat population major bleeding multicentre occurred Open-label outcome Patient patients prevention primary analysis randomised Randomised trial Randomly receive Registered registry risk rivaroxaban screened Standard dose study group symptomatic Thromboembolism Thromboprophylaxis thrombotic event Trial Two patient venous Venous Thromboembolism with COVID-19 withdrawal of consent [DOI] 10.1016/S0140-6736(21)02392-8 PMC 바로가기 [Article Type] Randomized Controlled Trial
Virtual risk assessment pathway for deep venous thrombosis: a preliminary modelObservational Study Published on 2022-01-012023-07-05 Journal: Postgraduate medical journal [Category] SARS, [키워드] bleeding disorders & Cardiology Coagulopathies education & Haematology health economics health services administration & management Thromboembolism training (see medical education & training) vascular medicine [DOI] 10.1136/postgradmedj-2020-138837 [Article Type] Observational Study